Vendor review
Andy Peps Studio reviews
Andy Peps Studio reviews from 44 independent lab tests (Tirzepatide, Retatrutide and BPC-157): grade A, purity and fill accuracy. Is Andy Peps Studio legit? See what its vials showed.
What the lab tests show
44 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Tirzepatide | 99.9 % | 24.3 mg of 20 mg (22 %) | Pass | View |
| Sep 30, 2026 | Tirzepatide | 99.99 % | 134.22 mg of 120 mg (12 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 99.9 % | 28.7 mg of 30 mg (-4 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 99.9 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 100 % | 13.3167 mg of 10 mg (33 %) | Pass | View |
| Aug 4, 2026 | Tirzepatide | 99.9 % | 31.4 mg of 30 mg (5 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 99.9 % | 5.28 mg of 5 mg (6 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 9.42 mg of 10 mg (-6 %) | Pass | View |
| May 28, 2026 | Tirzepatide | 99.9 % | 31 mg of 30 mg (3 %) | Pass | View |
| May 27, 2026 | BPC-157 | 97.4 % | 10 mg of 10 mg (0 %) | Pass | View |
| May 19, 2026 | Tirzepatide | 99.9 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| May 19, 2026 | Retatrutide | 99.9 % | 29.1 mg of 30 mg (-3 %) | Pass | View |
| Apr 28, 2026 | BPC-157 | 99.9 % | 9.66 mg of 10 mg (-3 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 41 mg of 40 mg (2 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 31.7 mg of 35.52 mg (-11 %) | Pass | View |
| Mar 13, 2026 | Tirzepatide | 99.7 % | 35.8 mg of 30 mg (19 %) | Pass | View |
| Mar 13, 2026 | Tirzepatide | 99.7 % | 67.8 mg of 60 mg (13 %) | Pass | View |
| Mar 6, 2026 | Tesamorelin | 99.9 % | 9.29 mg of 10 mg (-7 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 30.8 mg of 30 mg (3 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 9.56 mg of 10 mg (-4 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.9 % | 87.7 mg of 90 mg (-3 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.9 % | 22.2 mg of 20 mg (11 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 99.79 % | 11 mg of 10 mg (10 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.9 % | 24.7 mg of 30 mg (-18 %) | Pass | View |
| Feb 10, 2026 | Tesamorelin | 99.6 % | 6.9 mg of 10 mg (-31 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.7 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.7 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Feb 2, 2026 | Retatrutide | 99.82 % | 9.49 mg of 10 mg (-5 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.8 % | 32.6 mg of 30 mg (9 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.8 % | 33.4 mg of 30 mg (11 %) | Pass | View |
| Nov 6, 2025 | Tesamorelin | 97.72 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Oct 9, 2025 | BPC-157 | 99.54 % | 9.65 mg of 10 mg (-3 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.79 % | 9.52 mg of 10 mg (-5 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.87 % | 9.28 mg of 10 mg (-7 %) | Pass | View |
| Oct 2, 2025 | BPC-157 | 99.8 % | 12 mg of 10 mg (20 %) | Pass | View |
| Oct 2, 2025 | BPC-157 | 99.9 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.95 % | 9.32 mg of 10 mg (-7 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.93 % | 9.07 mg of 10 mg (-9 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.88 % | 9.27 mg of 10 mg (-7 %) | Pass | View |
| Aug 21, 2025 | Tirzepatide | 99.82 % | 15.7 mg of 15 mg (5 %) | Pass | View |
| Aug 15, 2025 | BPC-157 | 99.564 % | 10.74 mg of 10 mg (7 %) | Pass | View |
| Aug 12, 2025 | Retatrutide | 99.435 % | 21.92 mg of 20 mg (10 %) | Pass | View |
What Andy Peps Studio sells
No current listings on record.
About Andy Peps Studio
https://www.instagram.com/andy_peps_studio/